179 related articles for article (PubMed ID: 19081034)
21. Human gene mutations. Gene symbol: HRPT2. Disease: Hyperparathyroidism Jaw-tumor syndrome.
Teh BT; Howell VM; Haven CJ; Kahnoski K; Khoo SK; Petillo D; Chen J; Fleuren GJ; Robinson BG; Delbridge LW; Philips J; Nelson AE; Krause U; Hammje K; Dralle H; Hoang-Vu C; Gimm O; Marsh DJ; Morreau H
Hum Genet; 2004 Jan; 114(2):223. PubMed ID: 15046107
[No Abstract] [Full Text] [Related]
22. Human gene mutations. Gene symbol: HRPT2. Disease: Hyperparathyroidism Jaw-tumor syndrome.
Teh BT; Howell VM; Haven CJ; Kahnoski K; Khoo SK; Petillo D; Chen J; Fleuren GJ; Robinson BG; Delbridge LW; Philips J; Nelson AE; Krause U; Hammje K; Dralle H; Hoang-Vu C; Gimm O; Marsh DJ; Morreau H
Hum Genet; 2004 Jan; 114(2):223. PubMed ID: 15046105
[No Abstract] [Full Text] [Related]
23. Human gene mutations. Gene symbol: HRPT2. Disease: Hyperparathyroidism Jaw-tumor syndrome.
Teh BT; Howell VM; Haven CJ; Kahnoski K; Khoo SK; Petillo D; Chen J; Fleuren GJ; Robinson BG; Delbridge LW; Philips J; Nelson AE; Krause U; Hammje K; Dralle H; Hoang-Vu C; Gimm O; Marsh DJ; Morreau H
Hum Genet; 2004 Jan; 114(2):223. PubMed ID: 15046102
[No Abstract] [Full Text] [Related]
24. Human gene mutations. Gene symbol: HRPT2. Disease: Hyperparathyroidism Jaw-tumor syndrome.
Teh BT; Howell VM; Haven CJ; Kahnoski K; Khoo SK; Petillo D; Chen J; Fleuren GJ; Robinson BG; Delbridge LW; Philips J; Nelson AE; Krause U; Hammje K; Dralle H; Hoang-Vu C; Gimm O; Marsh DJ; Morreau H
Hum Genet; 2004 Jan; 114(2):222. PubMed ID: 15046098
[No Abstract] [Full Text] [Related]
25. Human gene mutations. Gene symbol: HRPT2. Disease: Hyperparathyroidism Jaw-tumor syndrome.
Teh BT; Howell VM; Haven CJ; Kahnoski K; Khoo SK; Petillo D; Chen J; Fleuren GJ; Robinson BG; Delbridge LW; Philips J; Nelson AE; Krause U; Hammje K; Dralle H; Hoang-Vu C; Gimm O; Marsh DJ; Morreau H
Hum Genet; 2004 Jan; 114(2):222. PubMed ID: 15046094
[No Abstract] [Full Text] [Related]
26. Sensitivity of HRPT2 mutation screening to detect parathyroid carcinoma and atypical parathyroid adenoma of Thai patients.
Niramitmahapanya S; Sunthornthepvarakul T; Deerochanawong C; Sarinnapakorn V; Athipan P; Harnsomboonvana P; Kongsaengdao S
J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S17-22. PubMed ID: 21717873
[TBL] [Abstract][Full Text] [Related]
27. Hyperparathyroidism-jaw Tumor Syndrome Confirmed by Preoperative Genetic Testing.
Koikawa K; Okada Y; Mori H; Kawaguchi M; Uchino S; Tanaka Y
Intern Med; 2018 Mar; 57(6):841-844. PubMed ID: 29225260
[TBL] [Abstract][Full Text] [Related]
28. [Clinical and morphological characteristics of parathyroid carcinoma].
Voronkova IA; Mokrysheva NG; Kazantseva IA; Gurevich LE
Arkh Patol; 2018; 80(4):65-72. PubMed ID: 30059074
[TBL] [Abstract][Full Text] [Related]
29. Different somatic alterations of the HRPT2 gene in a patient with recurrent sporadic primary hyperparathyroidism carrying an HRPT2 germline mutation.
Cetani F; Pardi E; Ambrogini E; Viacava P; Borsari S; Lemmi M; Cianferotti L; Miccoli P; Pinchera A; Arnold A; Marcocci C
Endocr Relat Cancer; 2007 Jun; 14(2):493-9. PubMed ID: 17639062
[TBL] [Abstract][Full Text] [Related]
30. Human gene mutations. Gene symbol: HRPT2. Disease: Hyperparathyroidism Jaw-tumor syndrome.
Teh BT; Howell VM; Haven CJ; Kahnoski K; Khoo SK; Petillo D; Chen J; Fleuren GJ; Robinson BG; Delbridge LW; Philips J; Nelson AE; Krause U; Hammje K; Dralle H; Hoang-Vu C; Gimm O; Marsh DJ; Morreau H
Hum Genet; 2004 Jan; 114(2):221. PubMed ID: 15046050
[No Abstract] [Full Text] [Related]
31. HRPT2-related familial isolated hyperparathyroidism: could molecular studies direct the surgical approach?
Silveira LG; Dias EP; Marinho BC; Gomez RS; De Marco L; Sarquis MS
Arq Bras Endocrinol Metabol; 2008 Nov; 52(8):1211-20. PubMed ID: 19169472
[TBL] [Abstract][Full Text] [Related]
32. A Young Male with Parafibromin-Deficient Parathyroid Carcinoma Due to a Rare Germline HRPT2/CDC73 Mutation.
Kapur A; Singh N; Mete O; Hegele RA; Fantus IG
Endocr Pathol; 2018 Dec; 29(4):374-379. PubMed ID: 30361844
[TBL] [Abstract][Full Text] [Related]
33. Loss of parafibromin expression in a subset of parathyroid adenomas.
Juhlin C; Larsson C; Yakoleva T; Leibiger I; Leibiger B; Alimov A; Weber G; Höög A; Villablanca A
Endocr Relat Cancer; 2006 Jun; 13(2):509-23. PubMed ID: 16728578
[TBL] [Abstract][Full Text] [Related]
34. A germline mutation of HRPT2/CDC73 (70 G>T) in an adolescent female with parathyroid carcinoma: first case report and a review of the literature.
Serrano-Gonzalez M; Shay S; Austin J; Maceri DR; Pitukcheewanont P
J Pediatr Endocrinol Metab; 2016 Sep; 29(9):1005-12. PubMed ID: 27544721
[TBL] [Abstract][Full Text] [Related]
35. Primary hyperparathyroidism: pathology, flow cytometric DNA analysis, and surgical treatment.
Bonjer HJ; Bruining HA; Bagwell CB; Jones MA; Nishiyama RH
Crit Rev Clin Lab Sci; 1992; 29(1):1-30. PubMed ID: 1388707
[No Abstract] [Full Text] [Related]
36. CDC73-related hereditary hyperparathyroidism: five new mutations and the clinical spectrum.
Frank-Raue K; Haag C; Schulze E; Keuser R; Raue F; Dralle H; Lorenz K
Eur J Endocrinol; 2011 Sep; 165(3):477-83. PubMed ID: 21652691
[TBL] [Abstract][Full Text] [Related]
37. Hyperparathyroidism 2 gene (HRPT2, CDC73) and parafibromin studies in two patients with primary hyperparathyroidism and uncertain pathological assessment.
Cetani F; Pardi E; Ambrogini E; Banti C; Viacava P; Borsari S; Bilezikian JP; Pinchera A; Marcocci C
J Endocrinol Invest; 2008 Oct; 31(10):900-4. PubMed ID: 19092296
[TBL] [Abstract][Full Text] [Related]
38. A case of hyperparathyroidism-jaw tumour syndrome found in the treatment of an ossifying fibroma in the maxillary bone.
Yamashita Y; Akiyama T; Mizusawa N; Yoshimoto K; Goto M
Int J Oral Maxillofac Surg; 2007 Apr; 36(4):365-9. PubMed ID: 17052894
[TBL] [Abstract][Full Text] [Related]
39. [Four cases of parathyroid cancer].
Chew-Wong A; Herrera MF; Jiménez ED; Gamboa-Domínguez A; Richaud-Patin Y; Bezaury P; Reza-A A; Correa-Rotter R; Rull JA
Rev Invest Clin; 1998; 50(3):239-44. PubMed ID: 9763890
[TBL] [Abstract][Full Text] [Related]
40. Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification.
Juhlin CC; Villablanca A; Sandelin K; Haglund F; Nordenström J; Forsberg L; Bränström R; Obara T; Arnold A; Larsson C; Höög A
Endocr Relat Cancer; 2007 Jun; 14(2):501-12. PubMed ID: 17639063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
